Literature DB >> 21353279

Glycosylation of the hemagglutinin modulates the sensitivity of H3N2 influenza viruses to innate proteins in airway secretions and virulence in mice.

Michelle D Tate1, Emma R Job, Andrew G Brooks, Patrick C Reading.   

Abstract

Collectins in airway fluids and membrane-associated lectins such as the macrophage mannose receptor (MMR) recognize mannose-rich glycans on the envelope glycoproteins of influenza A viruses. In this study, we used a reverse genetic approach to examine the role of particular N-linked glycosylation sites on the hemagglutinin (HA) of A/Beijing/353/89 (Beij/89, H3N2) in determining sensitivity to lectin-mediated immune defenses and virulence in mice. We generated 7:1 reassortant viruses on an A/PR/8/34 'backbone' with Beij/89 HA or HA lacking one or more glycosylation sites. Asn(165) was an important determinant of sensitivity to mouse collectins and virulence but did not alter susceptibility of airway macrophages to infection. Removal of both Asn(165) and Asn(246) led to a further increase in virulence, characterized by enhanced virus replication, pulmonary inflammation and vascular leak. These studies define the importance of particular glycans on H3 HA in determining sensitivity to airway collectins and virulence in mice.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21353279     DOI: 10.1016/j.virol.2011.01.036

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

1.  Loss and gain of N-linked glycosylation sites in globular head and stem of HA found in A/H3N2 flu fatal and severe cases during 2013 Tunisia flu seasonal survey.

Authors:  Awatef El Moussi; Mohamed Ali Ben Hadj Kacem; Amine Slim
Journal:  Virus Genes       Date:  2013-10-31       Impact factor: 2.332

2.  Antigenic and immunogenic properties of recombinant hemagglutinin proteins from H1N1 A/Brisbane/59/07 and B/Florida/04/06 when produced in various protein expression systems.

Authors:  Felix W Santiago; Kris Lambert Emo; Theresa Fitzgerald; John J Treanor; David J Topham
Journal:  Vaccine       Date:  2012-05-15       Impact factor: 3.641

3.  Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses.

Authors:  Rafael A Medina; Silke Stertz; Balaji Manicassamy; Petra Zimmermann; Xiangjie Sun; Randy A Albrecht; Hanni Uusi-Kerttula; Osvaldo Zagordi; Robert B Belshe; Sharon E Frey; Terrence M Tumpey; Adolfo García-Sastre
Journal:  Sci Transl Med       Date:  2013-05-29       Impact factor: 17.956

Review 4.  Soluble host defense lectins in innate immunity to influenza virus.

Authors:  Wy Ching Ng; Michelle D Tate; Andrew G Brooks; Patrick C Reading
Journal:  J Biomed Biotechnol       Date:  2012-05-16

Review 5.  Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection.

Authors:  Michelle D Tate; Emma R Job; Yi-Mo Deng; Vithiagaran Gunalan; Sebastian Maurer-Stroh; Patrick C Reading
Journal:  Viruses       Date:  2014-03-14       Impact factor: 5.048

Review 6.  N-linked glycosylation in the hemagglutinin of influenza A viruses.

Authors:  Jin Il Kim; Man-Seong Park
Journal:  Yonsei Med J       Date:  2012-09       Impact factor: 2.759

7.  Glycosylation on hemagglutinin affects the virulence and pathogenicity of pandemic H1N1/2009 influenza A virus in mice.

Authors:  Yan Zhang; Jiping Zhu; Yongtao Li; Konrad C Bradley; Jiyue Cao; Huanchun Chen; Meilin Jin; Hongbo Zhou
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

8.  A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors.

Authors:  Jutatip Panaampon; Nathamon Ngaosuwankul; Ornpreya Suptawiwat; Pirom Noisumdaeng; Kantima Sangsiriwut; Bunpote Siridechadilok; Hatairat Lerdsamran; Prasert Auewarakul; Phisanu Pooruk; Pilaipan Puthavathana
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

9.  Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice.

Authors:  Xunlong Shi; Wei Zhou; Hai Huang; Hongguang Zhu; Pei Zhou; Haiyan Zhu; Dianwen Ju
Journal:  Crit Care       Date:  2013-12-27       Impact factor: 9.097

10.  Re-emergence of H3N2 strains carrying potential neutralizing mutations at the N-linked glycosylation site at the hemagglutinin head, post the 2009 H1N1 pandemic.

Authors:  Hiroshi Ushirogawa; Tadasuke Naito; Hirotoshi Tokunaga; Toshihiro Tanaka; Takashi Nakano; Kihei Terada; Masanobu Ohuchi; Mineki Saito
Journal:  BMC Infect Dis       Date:  2016-08-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.